Jennifer Freiling

VP, Marketing & Commercial Operations at Quantgene

Jennifer oversees the strategy and implementation of Quantgene’s marketing and commercial operations across Quantgene's various lines of business. She manages the marketing team and is working to build out the department structure as the company continues to grow.

Jennifer brings with her 14 years of healthcare marketing and advertising experience. She has deep expertise in strategic patient-centric marketing having worked with world-leading companies including Gilead, J&J, Merck, Sanofi and Lilly. She has also led the launch of several pharmaceutical brands including Cialis for BPH, Sanofi’s insulin Toujeo and the omni-channel support platform for Gilead’s Hepatitis C portfolio. Most recently, Jennifer held the role of Group Account Director at Wunderman Health overseeing multiple pieces of business with a focus on data-driven marketing.

Jennifer spent 9 years growing up in Tokyo Japan; an experience that has added to her understanding of diversity and nuance in her work. Jennifer has a B.A. in Psychology from Columbia University’s Barnard College.


Org chart


Teams


Offices

This person is not in any offices


Quantgene

Medical technology now allows for cancer to be detected in a patient’s blood through cell-free DNA (cfDNA). Quantgene has developed a method for Deep Human Genome sequencing which allows us to see mutational patterns of disease down to a single molecule. This means diseases like cancer can be detected far earlier than ever before.


Industries

Employees

51-200

Links